Literature DB >> 28054213

Visual outcome and refractive status in first 3 years of age in preterm infants suffered from laser-treated Type 1 retinopathy of prematurity (ROP): a 6-year retrospective review in a tertiary centre in Hong Kong.

Julie Y C Lok1, Wilson W K Yip2, Abbie S W Luk2, Joyce K Y Chin2, Henry H W Lau2, Alvin L Young2.   

Abstract

PURPOSE: To report the visual outcome and refractive status in first 3 years of age in preterm infants suffered from laser-treated Type 1 retinopathy of prematurity (ROP): a 6-year review in Hong Kong
DESIGN: Retrospective case series
METHODOLOGY: Clinical records of all infants suffered from Type 1 ROP who had undergone laser therapy between 2007 and 2012 were retrospectively reviewed. Basic demographic data, serial changes of refractive error, visual acuity, severity of ROP and laser were analyzed. Correlation with myopia and astigmatism progression, body weight, height, growth and gestational age were also analyzed. RESULT: Among 494 babies screened, 14 Chinese babies (26 eyes) recruited with 1:1 male-to-female ratio in this study. All eyes showed gradual progression of myopia in first 3 years of age but no significant change of astigmatism. Further correlation analysis showed no correlation with laser energy consumed, birth weight (p = 0.14), head circumference growth (p = 0.57) and body weight growth (p = 0.71). However, severity of myopia was related to the post-conceptual age when receiving laser therapy (p < 0.005), gestation age (p = 0.02) and possibly body height growth with age (p = 0.05).
CONCLUSION: Myopia in early life is one of the most common ocular sequelae in Type 1 ROP survivors. Early detection of refractive error is important for prompt correction and visual rehabilitation to prevent amblyopia.

Entities:  

Keywords:  Laser; Late sequelae; Myopia; Refractive error; Retinopathy of prematurity

Mesh:

Year:  2017        PMID: 28054213     DOI: 10.1007/s10792-016-0439-5

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  38 in total

1.  Incidence, progression, and duration of retinopathy of prematurity in Hispanic and white non-Hispanic infants.

Authors:  Kyle J Eliason; J Dane Osborn; Eric Amsel; Scott C Richards
Journal:  J AAPOS       Date:  2007-05-10       Impact factor: 1.220

Review 2.  Retinopathy of prematurity.

Authors:  Ann Hellström; Lois E H Smith; Olaf Dammann
Journal:  Lancet       Date:  2013-06-17       Impact factor: 79.321

3.  Maternal and neonatal factors associated with poor early weight gain and later retinopathy of prematurity.

Authors:  Margareta Hök Wikstrand; Anna-Lena Hård; Aimon Niklasson; Lois Smith; Chatarina Löfqvist; Ann Hellström
Journal:  Acta Paediatr       Date:  2011-07-18       Impact factor: 2.299

4.  Intravitreal Bevacizumab in Retinopathy of Prematurity: Inject or Not?

Authors:  Dini Hapsari; Rita S Sitorus
Journal:  Asia Pac J Ophthalmol (Phila)       Date:  2014 Nov-Dec

5.  Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: ophthalmological outcomes at 10 years.

Authors: 
Journal:  Arch Ophthalmol       Date:  2001-08

6.  Refractive status and optical components of premature babies with or without retinopathy of prematurity at 3-4 years old.

Authors:  Li-Juan Ouyang; Zheng-Qin Yin; Ning Ke; Xin-Ke Chen; Qin Liu; Jing Fang; Lin Chen; Xiu-Rong Chen; Hui Shi; Ling Tang; Lian-Hong Pi
Journal:  Int J Clin Exp Med       Date:  2015-07-15

7.  Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial.

Authors:  William V Good
Journal:  Trans Am Ophthalmol Soc       Date:  2004

8.  Intravitreal bevacizumab for retinopathy of prematurity: refractive error results.

Authors:  Björn C Harder; Frank C Schlichtenbrede; Stefan von Baltz; Waldemar Jendritza; Bettina Jendritza; Jost B Jonas
Journal:  Am J Ophthalmol       Date:  2013-03-12       Impact factor: 5.258

9.  Development of refractive error in individual children with regressed retinopathy of prematurity.

Authors:  Jingyun Wang; Xiaowei Ren; Li Shen; Susan E Yanni; Joel N Leffler; Eileen E Birch
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-05       Impact factor: 4.799

Review 10.  Supplemental oxygen for the treatment of prethreshold retinopathy of prematurity.

Authors:  J Lloyd; L Askie; J Smith; W Tarnow-Mordi
Journal:  Cochrane Database Syst Rev       Date:  2003
View more
  3 in total

1.  Risk factors for early-onset high myopia after treatment for retinopathy of prematurity.

Authors:  Saiko Matsumura; Tadashi Matsumoto; Yuji Katayama; Masahiko Tomita; Hazuki Morikawa; Takashi Itokawa; Momoko Kawakami; Yuichi Hori
Journal:  Jpn J Ophthalmol       Date:  2022-04-30       Impact factor: 2.447

2.  Development of myopia in laser-treated ROP infants: prematurity or laser photocoagulation?

Authors:  Eşay Kıran Yenice; Caner Kara
Journal:  Int Ophthalmol       Date:  2022-09-23       Impact factor: 2.029

3.  Factors associated with refractive outcome in children treated with bevacizumab for retinopathy of prematurity: the importance of retinal vascularization.

Authors:  Sadik Etka Bayramoglu; Nihat Sayin
Journal:  Int Ophthalmol       Date:  2022-05-17       Impact factor: 2.029

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.